Therapeutics Acquisition (RACA) Stock Price, News & Analysis

Company Overview

Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was incorporated in 2020 and is based in Boston, Massachusetts.

Key Stats

• Today's Range: N/A
• 50-Day Range: $7.67 to $10.48
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 105,531 shs
• Market Capitalization: $175.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RACA Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Therapeutics Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Therapeutics Acquisition investors own include Churchill Capital Corp IV (CCIV), Gores Holdings IV (GHIV), Qell Acquisition (QELLU), Altimeter Growth (AGCUU), AGBA Acquisition (AGBA), Edoc Acquisition (ADOCU) and ArcLight Clean Transition (ACTCU).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:RACA
• CIK: N/A
• Web: www.researchalliancecorp.com
• Phone: 617 778 2500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.13
• Quick Ratio: 0.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 14,041,000
• Free Float: N/A
• Market Cap: $175.51 million
• Optionable: Not Optionable
• Beta: N/A